Lymphocytic Leukemia
Dr. Chiorazzi trained at North Shore
University Hospital and returned 13 years
later as a scientist. It was at this time
that he made discoveries in CLL B cells,
which compelled Dr. Chiorazzi to turn
his focus exclusively to CLL. He and his
colleagues in the center have investigated
the control of CLL B cell activation, and
their findings have significantly impacted
the understanding of leukemia cells in
patients with CLL. Dr. Chiorazzi continues
to conduct research in the hopes of curing
the disease.
LYMPHOCYTIC LEUKEMIA
Lymphocytic Leukemia study
the activation and maturation
of B-lymphocytes, and use this
information to develop and test
new diagnostics and treatments
for patients suff ering from chronic
lymphocytic leukemia (CLL).
CLL is a B-lymphocyte cancer
that resides in the blood, bone
marrow and lymphoid tissues.
It is the most common type of
leukemia in adults. It is called
"chronic" because it progresses
more slowly than other types
of leukemia.